Victoria J. Sinibaldi

American Cancer Society prostate cancer survivorship care guidelines

Ted A. Skolarus, Andrew M. D. Wolf, Nicole L. Erb et al. · CA A Cancer Journal for Clinicians · 2014 · 403 citations · Full text

Medicine, Health Promotion, Oncology +17

A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule.

Michael A. Carducci, Jeremy L. Gilbert, M K Bowling et al. · PubMed · 2001 · 204 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study

Benjamin A. Teply, Hao Wang, Brandon Luber et al. · The Lancet Oncology · 2017 · 195 citations · Full text

Medicine, Oncology, Urology +16

Atrasentan, an Endothelin-Receptor Antagonist for Refractory Adenocarcinomas: Safety and Pharmacokinetics

Michael A. Carducci, Joel B. Nelson, M. Kathy Bowling et al. · Journal of Clinical Oncology · 2002 · 160 citations

Medicine, Oncology, Pharmacology +13

Phase II evaluation of docetaxel plus one‐day oral estramustine phosphate in the treatment of patients with androgen independent prostate carcinoma

Victoria J. Sinibaldi, Michael A. Carducci, S. Moore-Cooper et al. · Cancer · 2002 · 138 citations

Medicine, Oncology, Pharmacology +10